13F

MGNX MACROGENICS INC

2026Q1 · CUSIP 556099109 · Sector: Healthcare & Biotech

🟢 Lit · Institutions accelerating in
Holders
108
Δ holders QoQ
+20
Breadth percentile
Top 16%
Whale holders
59
Δ whales
+7
Inst. holding value
$125M
New positions
32
Closed positions
12
Price momentum (1Q)
Put / Call
2/3

Breadth history (34 quarters)

2018Q1: Δ+14 · h=133 2018Q2: Δ-7 · h=126 2018Q3: Δ+5 · h=131 2018Q4: Δ+3 · h=134 2019Q1: Δ+24 · h=158 2019Q2: Δ-26 · h=132 2019Q3: Δ-4 · h=128 2019Q4: Δ-3 · h=125 2020Q1: Δ-3 · h=122 2020Q2: Δ+15 · h=137 2020Q3: Δ+2 · h=139 2020Q4: Δ+8 · h=147 2021Q1: Δ+28 · h=175 2021Q2: Δ-22 · h=153 2021Q3: Δ+3 · h=156 2021Q4: Δ+2 · h=158 2022Q1: Δ-14 · h=144 2022Q2: Δ-11 · h=133 2022Q3: Δ+4 · h=137 2022Q4: Δ+1 · h=138 2023Q1: Δ+0 · h=138 2023Q2: Δ-6 · h=132 2023Q3: Δ-3 · h=129 2023Q4: Δ+14 · h=143 2024Q1: Δ+21 · h=164 2024Q2: Δ-17 · h=147 2024Q3: Δ-22 · h=125 2024Q4: Δ+5 · h=130 2025Q1: Δ-1 · h=129 2025Q2: Δ-15 · h=114 2025Q3: Δ-9 · h=105 2025Q4: Δ-17 · h=88 2026Q1: Δ+20 · h=108 2018Q1: holders=133 2018Q2: holders=126 2018Q3: holders=131 2018Q4: holders=134 2019Q1: holders=158 2019Q2: holders=132 2019Q3: holders=128 2019Q4: holders=125 2020Q1: holders=122 2020Q2: holders=137 2020Q3: holders=139 2020Q4: holders=147 2021Q1: holders=175 2021Q2: holders=153 2021Q3: holders=156 2021Q4: holders=158 2022Q1: holders=144 2022Q2: holders=133 2022Q3: holders=137 2022Q4: holders=138 2023Q1: holders=138 2023Q2: holders=132 2023Q3: holders=129 2023Q4: holders=143 2024Q1: holders=164 2024Q2: holders=147 2024Q3: holders=125 2024Q4: holders=130 2025Q1: holders=129 2025Q2: holders=114 2025Q3: holders=105 2025Q4: holders=88 2026Q1: holders=108 -28 -14 +0 +14 +28 79132184 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 5 lit events

Period Percentile Next-1Q return Next-2Q return
2026Q1 Top 16%
2024Q1 Top 14% -18.7% -18.2%
2021Q1 Top 12% -24.1% -34.0%
2019Q1 Top 12% -19.5% -55.2%
2018Q1 Top 16% -4.9% -22.2%

Options Sentiment

Put holders
2
QoQ: +1
Call holders
3
QoQ: +2

See methodology →